The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in the Russell 1000 universe with positive recent consensus revisions to 2026 EPS estimates and that trade at attractive valuations. Goldman sees "more opportunity for alpha than beta" as wide return dispersion and increasing M&A activity in healthcare may favor selected winners.

NEEDHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced it will host a virtual Research and Development (R&D) Event from 11:00 am – 1:45 pm ET on Friday, December 5, 2025.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands”, “Tilray” or “the Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the release of its updated investor presentation, outlining the Company's strategic growth roadmap, category diversification, and financial performance milestones across its global platform.

CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

WARSAW, N.Y., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Financial Institutions, Inc. (Nasdaq: FISI) (the “Company”), parent company of Five Star Bank and Courier Capital, LLC, announced that on November 14, 2025, its Board of Directors approved a quarterly cash dividend of $0.31 per outstanding common share.

OAKLAND, Calif.--(BUSINESS WIRE)--ThredUp (NASDAQ: TDUP, LTSE: TDUP), one of the largest online resale platforms for apparel, shoes, and accessories, today announced the appointment of Kelly Bodnar Battles to its Board of Directors, with the appointment becoming effective on December 1, 2025. Upon the effective date, Battles will assume the role of Audit Committee Chair. This appointment reinforces ThredUp's continued commitment to strengthening its financial governance as the company accelerat.

JASPER, Ind.--(BUSINESS WIRE)--Kimball Electronics, Inc. (Nasdaq: KE) today announced the Company will participate in the 7th Annual Wolfe Research Healthcare Conference, which is being held November 17-19, 2025, at the Wolfe Research offices in New York, NY. Richard D. Phillips, Chief Executive Officer, and Jana T. Croom, Chief Financial Officer, are scheduled to present on Tuesday, November 18, 2025, at 10:40 a.m. Eastern Time. A webcast of the presentation will be available on the Events &am.

NELSONVILLE, Ohio--(BUSINESS WIRE)--Rocky Brands, Inc. (NASDAQ: RCKY) today announced that its board of directors has declared a quarterly cash dividend of $0.155 per share of outstanding common stock, which will be paid on December 15, 2025, to all shareholders of record as of the close of business on December 1, 2025. The declaration and payment of future dividends and the establishment of future record dates and payment dates are subject to the quarterly determination of the board of directo.

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence announced the appointment of Dr. Luc Van den hove to its board of directors, effective January 1, 2026.

ARLINGTON, Va.--(BUSINESS WIRE)--CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D digital twin technology in the property markets, will present at Stephens 27th Annual Investment Conference. CFO Chris Lown and Head of Investor Relations Rich Simonelli will participate in a fireside chat on Thursday, November 20, 2025, at 9:00 a.m. CT. Live and recorded versions of the webcast will both be available under the Events & Pr.

TULSA, Okla.--(BUSINESS WIRE)--Helmerich & Payne, Inc. (NYSE: HP) today announced that notice has been received to recommence operations on seven land rigs in Saudi Arabia that are currently under suspension. The reactivations will occur in stages throughout the first half of calendar year 2026. In accordance with the terms of the drilling contracts, all days accrued during each rig's suspension period will be added to its remaining contract. “These reactivations demonstrate the strong, lon.

OMAHA, Neb.--(BUSINESS WIRE)--Werner Enterprises, Inc. (Nasdaq: WERN), one of the nation's largest transportation and logistics companies, announced today that its Board of Directors declared a regular quarterly cash dividend of $0.14 (fourteen cents) per common share. This dividend will be paid on January 21, 2026, to stockholders of record at the close of business on January 5, 2026. Werner Enterprises has paid a quarterly cash dividend to its stockholders every quarter since July 1987. Werne.

SINGAPORE--(BUSINESS WIRE)--Seagate Technology Holdings plc (NASDAQ: STX), a leading innovator of mass-capacity data storage, announced that management is scheduled to participate in the following investor events: Event: UBS Global Technology and AI Conference on Monday, December 1, 2025 Details: Presentation at 3:15 PM PT / 6:15 PM ET Event: Nasdaq 53rd Annual Investor Conference on Tuesday, December 9, 2025 Details: Presentation at 6:30 AM PT / 9:30 AM ET Management will be hosting investor m.

Largest real-world analysis of AI-driven breast cancer screening in US demonstrates increased cancer detection rate, consistency across patient populations

TAMPA, Fla.--(BUSINESS WIRE)--American Integrity Insurance Group, Inc. (“American Integrity,” “we,” “us,” “our” and the “Company”) announced today the launch of an underwritten secondary public offering of 3,000,000 shares of its common stock by certain of its stockholders (the “Selling Stockholders”). In connection with the offering, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock at the public offering price.

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will present its latest research at the ESID/EHA/SIOPE Focused Symposium 2025 in Vienna, Austria, November 18-20. The poster presentation, titled “Comparing Mechanical Pump and Manual Push for Short-Duration Subcutaneous Infusions: A.

RADNOR, Pa.--(BUSINESS WIRE)-- #LiveUnited--Lincoln's John Muething will take on an expanded role as Vice President, FP&A, and Head of Investor Relations.

NEWARK, N.J.--(BUSINESS WIRE)--Prudential Financial, Inc. (NYSE: PRU) announced today the appointment of Tina Madon as global head of investor relations. In this role, Madon will lead Prudential's engagement with the investor community, partnering closely with its global leadership team to articulate Prudential's evolution to a higher-growth company. Madon begins Dec. 1 and will report to Executive Vice President and Chief Financial Officer Yanela Frias. Madon joins Prudential from Lincoln Fina.

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.

MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for gedatolisib in hormone receptor positive (“HR+”), human epidermal growth factor receptor 2 negative (“HER2-”), advanced breast cancer (“ABC”). The NDA was submitted under the FDA's Real-Time Oncology Review (“RTOR”) program, which is intended to facilitate shorter regulatory review periods. Gedatolisib previously received both Breakthrough Therapy and Fast Track designations based on promising preliminary clinical data. The …